| Lupin Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500257 |
NSE Symbol : LUPIN |
P/E(TTM) : 18.89 |
|
ISIN Demat : INE326A01037 |
Div & Yield% : 0.75 |
EPS(TTM) : 126.28 |
|
Book Value(₹) : 659.05 |
Market Cap(₹Cr) : 109,095.68 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 19,512.66 | 16,967.50 | 14,666.50 | 11,258.83 | 11,771.67 |
| Other Income | 1,346.44 | 253.39 | 115.51 | 210.02 | 216.99 |
| Stock Adjustments | -4.66 | 38.35 | 15.93 | -120.79 | 242.38 |
| Total Income | 20,854.44 | 17,259.24 | 14,797.94 | 11,348.06 | 12,231.04 |
| EXPENDITURE : | |||||
| Raw Materials | 4,870.68 | 4,963.57 | 5,041.16 | 4,676.90 | 4,709.64 |
| Power and Fuel Cost | 385.66 | 414.63 | 444.41 | 447.42 | 418.45 |
| Other Manufacturing Expenses | 1,591.55 | 1,268.19 | 1,182.52 | 1,155.60 | 1,209.09 |
| Selling and Administration Expenses | 2,745.98 | 2,352.64 | 2,264.54 | 1,797.13 | 1,573.22 |
| Miscellaneous Expenses | 192.79 | 378.83 | 204.01 | 162.95 | 1,976.35 |
| Employee Benefit Expenses | 2,544.88 | 2,312.07 | 2,095.51 | 1,934.14 | 1,918.16 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 8,522.90 | 5,569.31 | 3,565.79 | 1,173.92 | 426.13 |
| Interest | 121.47 | 84.50 | 56.35 | 98.44 | 73.47 |
| Gross Profit | 8,401.43 | 5,484.81 | 3,509.44 | 1,075.48 | 352.66 |
| Depreciation | 707.18 | 647.69 | 724.75 | 548.34 | 514.19 |
| Profit Before Tax | 7,694.25 | 4,837.12 | 2,784.69 | 527.14 | -161.53 |
| Current Tax | 1,351.29 | 857.12 | 484.05 | 95.89 | 57.80 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -23.60 | 7.04 | -25.45 | 6.04 | -30.63 |
| Reported Net Profit | 6,366.56 | 3,972.96 | 2,326.09 | 425.21 | -188.70 |
| Extraordinary Items | 592.55 | -27.20 | 23.78 | 14.42 | 30.64 |
| Adjusted Net Profit | 5,774.01 | 4,000.16 | 2,302.31 | 410.79 | -219.34 |
| Adjustment below Net Profit | 4.02 | -4.11 | -8.79 | -1.39 | 2.42 |
| Profit/Loss Balance carried down | 20,913.45 | 17,333.97 | 15,274.71 | 15,032.74 | 15,514.10 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 569.93 | 389.37 | 258.04 | 181.85 | 295.08 |
| P & L Balance carried down | 26,714.10 | 20,913.45 | 17,333.97 | 15,274.71 | 15,032.74 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 900.00 | 600.00 | 400.00 | 200.00 | 200.00 |
| Dividend Per Share(Rs) | 18.00 | 12.00 | 8.00 | 4.00 | 4.00 |
| Earnings Per Share-Unit Curr | 139.25 | 87.01 | 51.04 | 9.35 | -4.15 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 659.09 | 531.72 | 452.12 | 404.66 | 399.34 |
| Book Value(Adj)-Unit Curr | 659.09 | 531.72 | 452.12 | 404.66 | 399.34 |
